Pepper Bio

We’re treating untreatable diseases with the world's first transomics analysis platform. Pepper Bio, a venture-backed tech-bio startup founded by MIT, Harvard, and Northwestern alumni, has developed the world’s first transomic drug discovery platform. This ‘Google Maps’ for drug discovery brings not just more data but the right data to treat the untreatable. We integrate phosphoproteomics, proteomics, transcriptomics, and genomics. Pepper’s whole-stack solution to common drug discovery challenges reveals actionable insights that others miss. We have 3 ongoing oncology programs in early discovery. Read about our fall 2021 launch from stealth in TechCrunch: https://techcrunch.com/2021/10/15/nfx-backed-pepper-bio-emerges-from-stealth-with-tools-to-hone-in-on-complex-diseases We’re growing our software team to build out our core platform technology. You’ll work directly with the CSO (me, Samantha, Cofounder/CSO) and be joining engineers, physicists, and biologists driven to use actionable biological data to solve patient relevant challenges in drug discovery. Apply on LinkedIn: https://www.linkedin.com/jobs/pepper-bio-jobs-worldwide?f_C=74514076&trk=top-card_top-card-primary-button-top-card-primary-cta&position=1&pageNum=0